CVE-2026-1037Multiple vulnerabilities affect IBM License Key Server Administration and Reporting Tool and IBM LKS Administration Agent
Updated under an hour ago ()
Does this affect you?
It affects IBM Common Licensing. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
- CVSS
- 6.1 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
- Weakness (CWE)
- CWE-79
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- ibm
- NVD analysis
- Awaiting Analysis
- Record last updated
- Sep 18, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
IBM Common Licensing ibm:common_licensing | Agent 9.0; Agent 9.0.0.1; Agent 9.0.0.2; ART 9.0; ART 9.0.0.1; ART 9.0.0.2 | CNA record |
References
- https://www.ibm.com/support/pages/node/7286490vendor-advisory, patch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.